Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Concordia Financial, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 67%
7186 Concordia Financial Group, Ltd. 【J-GAAP】
Earnings ReportConcordia Financial Group, Ltd. <7186> [TSE Prime] announced its financial results after the market closed on February 5th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded 93.3 billion yen, an increase 67.2% compared to the same period last year. The progress rate toward the full-year plan of 120 billion yen was 77.8%, it was below the five-year average of 91.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to grow 25.8% from the same period last year, reaching 26.6 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 22.9% from the same period last year, reaching 29.1 billion yen.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 227,967 | ー | 66,773 | 45,782 | 38.6 | 83.6 | Feb 3, 2023 | J-GAAP |
Apr - Dec, 2023 | 261,689 | ー | 55,797 | 53,918 | 46.0 | 72.5 | Feb 5, 2024 | J-GAAP |
Apr - Dec, 2024 | 288,902 | ー | 93,320 | 62,758 | 54.1 | 77.8 | Feb 5, 2025 | J-GAAP |
YoY | +10.4% | - | +67.2% | +16.4% | +17.6% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 180,558 | ー | 44,911 | 29,093 | 24.9 | 12 | May 13, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | ー | ー | 55,804 | 34,194 | 30.0 | 14 | Nov 14, 2024 | J-GAAP |
YoY | - | - | +24.3% | +17.5% | +20.6% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 312,983 | ー | 79,870 | 56,159 | 47.4 | 19 | May 12, 2023 | J-GAAP |
Mar, 2024 | 358,303 | ー | 77,004 | 66,931 | 57.2 | 23 | May 13, 2024 | J-GAAP |
Mar, 2025 Guidance | ー | ー | 120,000 | 78,500 | 68.8 | 27 | Nov 14, 2024 | J-GAAP |
YoY | - | - | +55.8% | +17.3% | +20.3% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 83,944 | ー | 23,704 | 16,080 | 13.7 | 0.0 | Feb 5, 2024 | J-GAAP |
Jan - Mar, 2024 | 96,614 | ー | 21,207 | 13,013 | 11.1 | 0.0 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 92,624 | ー | 32,676 | 22,665 | 19.5 | 0.0 | Aug 5, 2024 | J-GAAP |
Jul - Sep, 2024 | 97,645 | ー | 31,520 | 21,641 | 18.6 | 0.0 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 98,633 | ー | 29,124 | 18,452 | 15.9 | 0.0 | Feb 5, 2025 | J-GAAP |
YoY | +17.5% | - | +22.9% | +14.8% | +16.0% |
Related Articles
DAIKIN INDUSTRIES, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%
ICHINEN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 27%, Oct-Dec Ordinary Profit Increases by 7%
Soken Chemical & Engineering, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 61%, Oct-Dec Ordinary Profit Increases by 5%
CUBE SYSTEM, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 18% Decrease
J-LEASE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 22%
KIKKOMAN, Apr-Dec (Cumulative 3Q) Net Income Increases by 13%
KYORIN Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Oct-Dec Ordinary Profit Decreases by 55%
FUJI KYUKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%
Noevir, Oct-Dec (1Q) Ordinary Profit Decreases by 8%
NIHON KOHDEN, Oct-Dec (3Q) Ordinary Profit Increases by 16 times